Acute experimental autoimmune encephalomyelitis induces sex dimorphic changes in neuroactive steroid levels

Neurochemistry International

Volumn 56, Issue 1, 2010, Pages 118-127

  Giatti, Silvia ^a   D'Intino, Giulia ^b   Maschi, Omar ^a   Pesaresi, Marzia ^a   Garcia Segura, Luis Miguel ^c   Calza, Laura ^b   Caruso, Donatella ^a   Melcangi, R C ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c INSTITUTO CAJAL   (Spain)

Author keywords

Central nervous system; GABA A receptor; Liquid chromatography tandem mass spectrometry; Multiple sclerosis; Neurosteroids; Pregnenolone; Progesterone; Rat; Steroid metabolism; Testosterone

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; NEUROSTEROID; PREGNENOLONE; PROGESTERONE; STEROID; TESTOSTERONE;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; FEMALE; LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; RAT; SEX DIFFERENCE; STEROID BLOOD LEVEL; STEROID METABOLISM; TANDEM MASS SPECTROMETRY;

20-ALPHA-DIHYDROPROGESTERONE; ACUTE DISEASE; ANDROSTANE-3,17-DIOL; ANIMALS; BRAIN; CHROMATOGRAPHY, LIQUID; DIHYDROTESTOSTERONE; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; MALE; MASS SPECTROMETRY; MULTIPLE SCLEROSIS; NEUROTRANSMITTER AGENTS; PREGNANOLONE; PROGESTERONE; RATS; SEX CHARACTERISTICS; TESTOSTERONE;

RATTUS;

EID: 73449092476     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2009.09.009     Document Type: Article

References (85)

1. Ahlbom E., Prins G.S., and Ceccatelli S. Testosterone protects cerebellar granule cells from oxidative stress-induced cell death through a receptor mediated mechanism. Brain Res. 892 (2001) 255-262
2. Backstrom T., Wahlstrom G., Wahlstrom K., Zhu D., and Wang M.D. Isoallopregnanolone; an antagonist to the anaesthetic effect of allopregnanolone in male rats. Eur. J. Pharmacol. 512 (2005) 15-21
3. Barnard A.L., Chidgey A.P., Bernard C.C., and Boyd R.L. Androgen depletion increases the efficacy of bone marrow transplantation in ameliorating experimental autoimmune encephalomyelitis. Blood 113 (2009) 204-213
4. Barreto G., Veiga S., Azcoitia I., Garcia-Segura L.M., and Garcia-Ovejero D. Testosterone decreases reactive astroglia and reactive microglia after brain injury in male rats: role of its metabolites, oestradiol and dihydrotestosterone. Eur. J. Neurosci. 25 (2007) 3039-3046
5. Baxter A.G. The origin and application of experimental autoimmune encephalomyelitis. Nat. Rev. Immunol. 7 (2007) 904-912
6. Bitran D., Hilvers R.J., and Kellogg C.K. Anxiolytic effects of 3 alpha-hydroxy-5 alpha[beta]-pregnan-20-one: endogenous metabolites of progesterone that are active at the GABAA receptor. Brain Res. 561 (1991) 157-161
7. Cabrelle A., Dell'Aica I., Melchiori L., Carraro S., Brunetta E., Niero R., Scquizzato E., D'Intino G., Calza L., Garbisa S., and Agostini C. Hyperforin down-regulates effector function of activated T lymphocytes and shows efficacy against Th1-triggered CNS inflammatory-demyelinating disease. J. Leukoc. Biol. 83 (2008) 212-219
8. Calza L., Fernandez M., Giuliani A., D'Intino G., Pirondi S., Sivilia S., Paradisi M., Desordi N., and Giardino L. Thyroid hormone and remyelination in adult central nervous system: a lesson from an inflammatory-demyelinating disease. Brain Res. Brain Res. Rev. 48 (2005) 339-346
9. Calza L., Giardino L., Pozza M., Micera A., and Aloe L. Time-course changes of nerve growth factor, corticotropin-releasing hormone, and nitric oxide synthase isoforms and their possible role in the development of inflammatory response in experimental allergic encephalomyelitis. Proc. Natl. Acad. Sci. U.S.A. 94 (1997) 3368-3373
10. Caruso D., Scurati S., Maschi O., De Angelis L., Roglio I., Giatti S., Garcia-Segura L.M., and Melcangi R.C. Evaluation of neuroactive steroid levels by liquid chromatography-tandem mass spectrometry in central and peripheral nervous system: effect of diabetes. Neurochem. Int. 52 (2008) 560-568
11. Ciriza I., Azcoitia I., and Garcia-Segura L.M. Reduced progesterone metabolites protect rat hippocampal neurones from kainic acid excitotoxicity in vivo. J. Neuroendocrinol. 16 (2004) 58-63
12. Ciriza I., Carrero P., Frye C.A., and Garcia-Segura L.M. Reduced metabolites mediate neuroprotective effects of progesterone in the adult rat hippocampus. The synthetic progestin medroxyprogesterone acetate (Provera) is not neuroprotective. J. Neurobiol. 66 (2006) 916-928
13. Coers S., Tanzer L., and Jones K.J. Testosterone treatment attenuates the effects of facial nerve transection on glial fibrillary acidic protein (GFAP) levels in the hamster facial motor nucleus. Metab. Brain Dis. 17 (2002) 55-63
14. Confavreux C., Vukusic S., and Adeleine P. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process. Brain 126 (2003) 770-782
15. Dalal M., Kim S., and Voskuhl R.R. Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response. J. Immunol. 159 (1997) 3-6
16. Darlington C. Multiple sclerosis and gender. Curr. Opin. Invest. Drugs 3 (2002) 911-914
17. Drew P.D., and Chavis J.A. Female sex steroids: effects upon microglial cell activation. J. Neuroimmunol. 111 (2000) 77-85
18. Ehrlich S., Haas J., Zipp F., and Infante-Duarte C. Serum levels of soluble CD95 are not associated with amelioration of multiple sclerosis during pregnancy. J. Neurol. Sci. 252 (2007) 83-87
19. El-Etr M., Vukusic S., Gignoux L., Durand-Dubief F., Achiti I., Baulieu E.E., and Confavreux C. Steroid hormones in multiple sclerosis. J. Neurol. Sci. 233 (2005) 49-54
20. Elloso M.M., Phiel K., Henderson R.A., Harris H.A., and Adelman S.J. Suppression of experimental autoimmune encephalomyelitis using estrogen receptor-selective ligands. J. Endocrinol. 185 (2005) 243-252
21. Fargo K.N., Foecking E.M., Jones K.J., and Sengelaub D.R. Neuroprotective actions of androgens on motoneurons. Front Neuroendocrinol. 30 (2009) 130-141
22. Fernandez M., Giuliani A., Pirondi S., D'Intino G., Giardino L., Aloe L., Levi-Montalcini R., and Calza L. Thyroid hormone administration enhances remyelination in chronic demyelinating inflammatory disease. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 16363-16368
23. Foster S.C., Daniels C., Bourdette D.N., and Bebo Jr. B.F. Dysregulation of the hypothalamic-pituitary-gonadal axis in experimental autoimmune encephalomyelitis and multiple sclerosis. J. Neuroimmunol. 140 (2003) 78-87
24. Franklin R.J., and Ffrench-Constant C. Remyelination in the CNS: from biology to therapy. Nat. Rev. Neurosci. 9 (2008) 839-855
25. Frye C.A., Koonce C.J., Edinger K.L., Osborne D.M., and Walf A.A. Androgens with activity at estrogen receptor beta have anxiolytic and cognitive-enhancing effects in male rats and mice. Horm. Behav. 54 (2008) 726-734
26. Frye C.A., Van Keuren K.R., and Erskine M.S. Behavioral effects of 3 alpha-androstanediol. I. Modulation of sexual receptivity and promotion of GABA-stimulated chloride flux. Behav. Brain Res. 79 (1996) 109-118
27. Gago N., Akwa Y., Sananes N., Guennoun R., Baulieu E.E., El-Etr M., and Schumacher M. Progesterone and the oligodendroglial lineage: stage-dependent biosynthesis and metabolism. Glia 36 (2001) 295-308
28. Ganter S., Northoff H., Mannel D., and Gebicke-Harter P.J. Growth control of cultured microglia. J. Neurosci. Res. 33 (1992) 218-230
29. Garay L., Deniselle M.C., Lima A., Roig P., and De Nicola A.F. Effects of progesterone in the spinal cord of a mouse model of multiple sclerosis. J. Steroid Biochem. Mol. Biol. 107 (2007) 228-237
30. Garay L., Gonzalez Deniselle M.C., Gierman L., Meyer M., Lima A., Roig P., and De Nicola A.F. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis. Neuroimmunomodulation 15 (2008) 76-83
31. Garcia-Estrada J., Del Rio J.A., Luquin S., Soriano E., and Garcia-Segura L.M. Gonadal hormones down-regulate reactive gliosis and astrocyte proliferation after a penetrating brain injury. Brain Res. 628 (1993) 271-278
32. Garidou L., Laffont S., Douin-Echinard V., Coureau C., Krust A., Chambon P., and Guery J.C. Estrogen receptor alpha signaling in inflammatory leukocytes is dispensable for 17beta-estradiol-mediated inhibition of experimental autoimmune encephalomyelitis. J. Immunol. 173 (2004) 2435-2442
33. Gee K.W., Bolger M.B., Brinton R.E., Coirini H., and McEwen B.S. Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action. J. Pharmacol. Exp. Ther. 246 (1988) 803-812
34. Ghoumari A.M., Baulieu E.E., and Schumacher M. Progesterone increases oligodendroglial cell proliferation in rat cerebellar slice cultures. Neuroscience 135 (2005) 47-58
35. Ghoumari A.M., Ibanez C., El-Etr M., Leclerc P., Eychenne B., O'Malley B.W., Baulieu E.E., and Schumacher M. Progesterone and its metabolites increase myelin basic protein expression in organotypic slice cultures of rat cerebellum. J. Neurochem. 86 (2003) 848-859
36. Gold R., Linington C., and Lassmann H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 129 (2006) 1953-1971
37. Hammond J., Le Q., Goodyer C., Gelfand M., Trifiro M., and LeBlanc A. Testosterone-mediated neuroprotection through the androgen receptor in human primary neurons. J. Neurochem. 77 (2001) 1319-1326
38. Hawkins S.A., and McDonnell G.V. Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors. J. Neurol. Neurosurg. Psychiatry 67 (1999) 148-152
39. Hickey W.F., Cohen J.A., and Burns J.B. A quantitative immunohistochemical comparison of actively versus adoptively induced experimental allergic encephalomyelitis in the Lewis rat. Cell Immunol. 109 (1987) 272-281
40. Hoffman G.E., Le W.W., Murphy A.Z., and Koski C.L. Divergent effects of ovarian steroids on neuronal survival during experimental allergic encephalitis in Lewis rats. Exp. Neurol. 171 (2001) 272-284
41. Holmqvist P., Wallberg M., Hammar M., Landtblom A.M., and Brynhildsen J. Symptoms of multiple sclerosis in women in relation to sex steroid exposure. Maturitas 54 (2006) 149-153
42. Houzen H., Niino M., Kikuchi S., Fukazawa T., Nogoshi S., Matsumoto H., and Tashiro K. The prevalence and clinical characteristics of MS in northern Japan. J. Neurol. Sci. 211 (2003) 49-53
43. Ibanez C., Shields S.A., El-Etr M., Baulieu E.E., Schumacher M., and Franklin R.J. Systemic progesterone administration results in a partial reversal of the age-associated decline in CNS remyelination following toxin-induced demyelination in male rats. Neuropathol. Appl. Neurobiol. 30 (2004) 80-89
44. Jones K.J., Coers S., Storer P.D., Tanzer L., and Kinderman N.B. Androgenic regulation of the central glia response following nerve damage. J. Neurobiol. 40 (1999) 560-573
45. Jones K.J., Kinderman N.B., and Oblinger M.M. Alterations in glial fibrillary acidic protein (GFAP) mRNA levels in the hamster facial motor nucleus: effects of axotomy and testosterone. Neurochem. Res. 22 (1997) 1359-1366
46. Kohchi C., Ukena K., and Tsutsui K. Age- and region-specific expressions of the messenger RNAs encoding for steroidogenic enzymes p450scc, P450c17 and 3beta-HSD in the postnatal rat brain. Brain Res. 801 (1998) 233-238
47. Kujawa K.A., Tanzer L., and Jones K.J. Inhibition of the accelerative effects of testosterone on hamster facial nerve regeneration by the antiandrogen flutamide. Exp. Neurol. 133 (1995) 138-143
48. Lambert J.J., Belelli D., Peden D.R., Vardy A.W., and Peters J.A. Neurosteroid modulation of GABAA receptors. Prog. Neurobiol. 71 (2003) 67-80
49. Lewis D.K., Johnson A.B., Stohlgren S., Harms A., and Sohrabji F. Effects of estrogen receptor agonists on regulation of the inflammatory response in astrocytes from young adult and middle-aged female rats. J. Neuroimmunol. 195 (2008) 47-59
50. Lundgren P., Stromberg J., Backstrom T., and Wang M. Allopregnanolone-stimulated GABA-mediated chloride ion flux is inhibited by 3beta-hydroxy-5alpha-pregnan-20-one (isoallopregnanolone). Brain Res. 982 (2003) 45-53
51. Maccio D.R., Calfa G., and Roth G.A. Oral testosterone in male rats and the development of experimental autoimmune encephalomyelitis. Neuroimmunomodulation 12 (2005) 246-254
52. Maccio D.R., Calfa G., Volosin M., and Roth G.A. Serum testosterone and corticosterone levels in acute experimental autoimmune encephalomyelitis (EAE) in male Wistar rats. Neuroendocrinol. Lett. 25 (2004) 196-200
53. Maccio D.R., Ditamo Y., Degano A.L., and Roth G.A. Interaction between gonadal steroids and neuroimmune system in acute experimental autoimmune encephalomyelitis (EAE) in Wistar rats. Autoimmunity 37 (2004) 17-25
54. Marin-Husstege M., Muggironi M., Raban D., Skoff R.P., and Casaccia-Bonnefil P. Oligodendrocyte progenitor proliferation and maturation is differentially regulated by male and female sex steroid hormones. Dev. Neurosci. 26 (2004) 245-254
55. Matejuk A., Dwyer J., Hopke C., Vandenbark A.A., and Offner H. 17Beta-estradiol treatment profoundly down-regulates gene expression in spinal cord tissue in mice protected from experimental autoimmune encephalomyelitis. Arch. Immunol. Ther. Exp. (Warsz) 51 (2003) 185-193
56. Matejuk A., Hopke C., Vandenbark A.A., Hurn P.D., and Offner H. Middle-age male mice have increased severity of experimental autoimmune encephalomyelitis and are unresponsive to testosterone therapy. J. Immunol. 174 (2005) 2387-2395
57. Meffre D., Pianos A., Liere P., Eychenne B., Cambourg A., Schumacher M., Stein D.G., and Guennoun R. Steroid profiling in brain and plasma of male and pseudopregnant female rats after traumatic brain injury: analysis by gas chromatography/mass spectrometry. Endocrinology 148 (2007) 2505-2517
58. Melcangi R.C., Garcia-Segura L.M., and Mensah-Nyagan A.G. Neuroactive steroids: state of the art and new perspectives. Cell Mol. Life Sci. 65 (2008) 777-797
59. Melcangi R.C., and Panzica G.C. Neuroactive steroids: old players in a new game. Neuroscience 138 (2006) 733-739
60. Mellon S.H., and Deschepper C.F. Neurosteroid biosynthesis: genes for adrenal steroidogenic enzymes are expressed in the brain. Brain Res. 629 (1993) 283-292
61. Muller E., and Kerschbaum H.H. Progesterone and its metabolites 5-dihydroprogesterone and 5-3-tetrahydroprogesterone decrease LPS-induced NO release in the murine microglial cell line, BV-2. Neuroendocrinol. Lett. 27 (2006) 675-678
62. Nicot A. Gender and sex hormones in multiple sclerosis pathology and therapy. Front Biosci. 14 (2009) 4477-4515
63. Noonan C.W., Kathman S.J., and White M.C. Prevalence estimates for MS in the United States and evidence of an increasing trend for women. Neurology 58 (2002) 136-138
64. Offner H. Neuroimmunoprotective effects of estrogen and derivatives in experimental autoimmune encephalomyelitis: therapeutic implications for multiple sclerosis. J. Neurosci. Res. 78 (2004) 603-624
65. Orton S.M., Herrera B.M., Yee I.M., Valdar W., Ramagopalan S.V., Sadovnick A.D., and Ebers G.C. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol. 5 (2006) 932-936
66. Palaszynski K.M., Liu H., Loo K.K., and Voskuhl R.R. Estriol treatment ameliorates disease in males with experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J. Neuroimmunol. 149 (2004) 84-89
67. Palaszynski K.M., Loo K.K., Ashouri J.F., Liu H.B., and Voskuhl R.R. Androgens are protective in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. J. Neuroimmunol. 146 (2004) 144-152
68. Pelfrey C.M., Moldovan I.R., Cotleur A.C., Zamor N., and Rudick R.A. Effects of sex hormones on costimulatory molecule expression in multiple sclerosis. J. Neuroimmunol. 167 (2005) 190-203
69. Pesaresi M., Maschi O., Giatti S., Garcia-Segura L.M., Caruso D., and Melcangi R.C. Sex differences in neuroactive steroid levels in the nervous system of diabetic and non-diabetic rats. Horm. Behav. (2009) 10.1016/j.yhbeh.2009.04.008
70. Polanczyk M., Zamora A., Subramanian S., Matejuk A., Hess D.L., Blankenhorn E.P., Teuscher C., Vandenbark A.A., and Offner H. The protective effect of 17beta-estradiol on experimental autoimmune encephalomyelitis is mediated through estrogen receptor-alpha. Am. J. Pathol. 163 (2003) 1599-1605
71. Pozzilli C., Tomassini V., Marinelli F., Paolillo A., Gasperini C., and Bastianello S. Gender gap in multiple sclerosis: magnetic resonance imaging evidence. Eur. J. Neurol. 10 (2003) 95-97
72. Roglio I., Bianchi R., Giatti S., Cavaletti G., Caruso D., Scurati S., Crippa D., Garcia-Segura L.M., Camozzi F., Lauria G., and Melcangi R.C. Testosterone derivatives are neuroprotective agents in experimental diabetic neuropathy. Cell Mol. Life Sci. 64 (2007) 1158-1168
73. Safarinejad M.R. Evaluation of endocrine profile, hypothalamic-pituitary-testis axis and semen quality in multiple sclerosis. J. Neuroendocrinol. 20 (2008) 1368-1375
74. Schwendimann R.N., and Alekseeva N. Gender issues in multiple sclerosis. Int. Rev. Neurobiol. 79 (2007) 377-392
75. Sicotte N.L., Giesser B.S., Tandon V., Klutch R., Steiner B., Drain A.E., Shattuck D.W., Hull L., Wang H.J., Elashoff R.M., Swerdloff R.S., and Voskuhl R.R. Testosterone treatment in multiple sclerosis: a pilot study. Arch. Neurol. 64 (2007) 683-688
76. Sicotte N.L., Liva S.M., Klutch R., Pfeiffer P., Bouvier S., Odesa S., Wu T.C., and Voskuhl R.R. Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann. Neurol. 52 (2002) 421-428
77. Tiwari-Woodruff S., Morales L.B., Lee R., and Voskuhl R.R. Differential neuroprotective and antiinflammatory effects of estrogen receptor (ER)alpha and ERbeta ligand treatment. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 14813-14818
78. Tomassini V., Onesti E., Mainero C., Giugni E., Paolillo A., Salvetti M., Nicoletti F., and Pozzilli C. Sex hormones modulate brain damage in multiple sclerosis: MRI evidence. J. Neurol. Neurosurg. Psychiatry 76 (2005) 272-275
79. Tomassini V., and Pozzilli C. Sex hormones: a role in the control of multiple sclerosis?. Expert Opin. Pharmacother. 7 (2006) 857-868
80. van den Broek H.H., Damoiseaux J.G., De Baets M.H., and Hupperts R.M. The influence of sex hormones on cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis: a review. Mult. Scler. 11 (2005) 349-359
81. Voskuhl R.R., and Palaszynski K. Sex hormones in experimental autoimmune encephalomyelitis: implications for multiple sclerosis. Neuroscientist 7 (2001) 258-270
82. Vukusic S., and Confavreux C. Pregnancy and multiple sclerosis: the children of PRIMS. Clin. Neurol. Neurosurg. 108 (2006) 266-270
83. Vukusic S., Hutchinson M., Hours M., Moreau T., Cortinovis-Tourniaire P., Adeleine P., and Confavreux C.G. Pregnancy and multiple sclerosis (the PRIMS study): clinical predictors of post-partum relapse. Brain 127 (2004) 1353-1360
84. Wang M., He Y., Eisenman L.N., Fields C., Zeng C.M., Mathews J., Benz A., Fu T., Zorumski E., Steinbach J.H., Covey D.F., Zorumski C.F., and Mennerick S. 3Beta-hydroxypregnane steroids are pregnenolone sulfate-like GABA(A) receptor antagonists. J. Neurosci. 22 (2002) 3366-3375
85. Zhang G.X., Yu S., Gran B., Li J., Siglienti I., Chen X., Calida D., Ventura E., Kamoun M., and Rostami A. Role of IL-12 receptor beta 1 in regulation of T cell response by APC in experimental autoimmune encephalomyelitis. J. Immunol. 171 (2003) 4485-4492